Eli Lilly to invest $1bn in Limerick drug-manufacturing site

Bio-pharma giant’s move will create 1,200 construction jobs and 300 new roles when operational

Eli Lilly says its site at Raheen will operate at 35 per cent lower energy intensity, use 40 per cent less water and produce 15 per cent less waste than traditional pharma manufacturing sites. Photograph: Simone Baribeau/Bloomberg

US bio-pharma giant Eli Lilly and Co announced a $1 billion (€927 million) investment in a medicine manufacturing site in Limerick which it said would deliver almost 1,500 new jobs.

Lilly which already employs almost 2,700 people at Kinsale and Little Island, Co Cork, aims to generate 1,200 jobs during the construction phase of its Limerick campus in Raheen, and 300 new jobs once it is fully operational.

The announcement was officially welcomed by the Minister for Enterprise, Trade and Employment, Simon Coveney, at a launch event on the Raheen site on Monday.

Lilly said its Limerick site would operate at 35 per cent lower energy intensity, use 40 per cent less water and produce 15 per cent less waste when compared to traditional pharma manufacturing sites.

READ MORE

Lilly chief executive and chairman David Ricks said the 140-year-old company had united caring with discovery to make life better for people around the world by bringing life-changing medicines to patients who need them and by giving back to communities.

“The Limerick manufacturing site will be a fully integrated digital site with the latest machine automation, manufacturing execution and data technologies designed to ensure product and data quality, and its integrated design will enable manufacturing excellence for the production and delivery of quality medicine,” Lilly said in a statement.

Eli Lilly, Regeneron antibody therapies lose out against OmicronOpens in new window ]

The new facility would aim to “expand Lilly’s manufacturing network for biologic active ingredients”, it said.

Since 1978 Lilly has had a growing presence in Ireland, forging close links “between the life sciences industry, communities and universities with strong science, technology, engineering and maths (Stem) programmes in Limerick and across the country”.

Lilly said it had a “long-standing commitment to sustainability and respecting the local environment” and had established “environmental programmes” to monitor the quality of ambient air and the local marine habitat at its Kinsale plant.

“Lilly Limerick has already developed a comprehensive plan for the management of the protected species of Meadow Barley (Hordeum secalinum) plant which is growing on the Raheen site.”

In July 2021, it opened what was at that time the “single largest solar farm in the Republic of Ireland” on 16 acres in Kinsale.

Poolbeg Pharma granted US patent related to influenza drugOpens in new window ]

The solar farm “now helps to power a portion of the Kinsale manufacturing facility with sustainable energy, reducing its annual carbon footprint at the site by 2,350 tonnes per annum”.

Lilly said its Limerick campus design also included plans for a “significant solar energy investment”.

“Based on current design estimates, Limerick is estimated to produce 3.17 million kWh of renewable solar energy per year, which is enough to power 755 homes in Ireland,” it said.

The Limerick site design also includes “an array of cisterns that will harvest rainwater for reuse within the site, resulting in a saving of roughly two million litres of water per annum”.